Literature DB >> 10415418

Effects of prenatal cocaine exposure on amphetamine-induced dopamine release in the caudate nucleus of the adult rabbit.

W Du1, V J Aloyo, P S Pazdelski, J A Harvey.   

Abstract

Acute amphetamine (AMPH) challenge has been used to probe the neurochemical and behavioral integrity of dopaminergic neurons under various conditions including prenatal cocaine exposure. In this study, we employed in vivo microdialysis to examine the effects of prenatal cocaine exposure on AMPH-induced dopamine (DA) release in the caudate nucleus of the awake adult rabbit. Pregnant rabbits were given intravenous injections of either saline or cocaine (4 mg/kg) twice a day from gestational day 8 (G8) through G29. Microdialysis was performed in adult saline and cocaine progeny at approximately postnatal day 70 (P70). There were no significant differences between cocaine and saline progeny in their basal concentrations of DA or its metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). AMPH (5 mg/kg, i.v.) significantly increased extracellular DA in the caudate of both groups. However, AMPH-induced DA release was 2 to 3-fold greater in cocaine progeny than in the saline controls. Although, DOPAC decreased in both groups following AMPH injection, there was no significant group effect. In addition, there were no significant changes in concentrations of HVA. AMPH is known to release DA by a mechanism of exchange diffusion via the presynaptic DA transporter (DAT). Therefore, we examined the binding of [(3)H]WIN 35,428 to membrane fractions prepared from fresh caudate tissue to determine whether prenatal exposure to cocaine had altered the density (B(max)) or affinity (K(d)) of the DAT. While the B(max) for [(3)H]WIN 35,428 binding increased 3-fold between P3 and P120, there were no significant differences between saline and cocaine progeny at any age examined. The K(d) for [(3)H]WIN 35,428 binding did not change with postnatal age and did not differ between cocaine and saline progeny. These findings suggest that prenatal exposure to cocaine produces a long-term increase in the size of the presynaptic, AMPH releasable, cytoplasmic pool of DA. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415418     DOI: 10.1016/s0006-8993(99)01567-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Serotonin 5-HT2A receptors in the CA1 field of the hippocampus mediate head movements in the rabbit.

Authors:  Kuldip D Dave; Gayani S Fernando; Jennifer L Quinn; John A Harvey; Vincent J Aloyo
Journal:  Psychopharmacology (Berl)       Date:  2004-04-24       Impact factor: 4.530

2.  Prenatal cocaine exposure increases sensitivity to the attentional effects of the dopamine D1 agonist SKF81297.

Authors:  L E Bayer; A Brown; C F Mactutus; R M Booze; B J Strupp
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

3.  In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons.

Authors:  L B Jones; G D Stanwood; B S Reinoso; R A Washington; H Y Wang; E Friedman; P Levitt
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

4.  Effects of prenatal exposure to cocaine on the developing brain: anatomical, chemical, physiological and behavioral consequences.

Authors:  J A Harvey; A G Romano; M Gabriel; K J Simansky; W Du; V J Aloyo; E Friedman
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

5.  Sustained exposure to the widely used herbicide atrazine: altered function and loss of neurons in brain monoamine systems.

Authors:  Veronica M Rodriguez; Mona Thiruchelvam; Deborah A Cory-Slechta
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

6.  Prenatal cocaine exposure alters alpha2 receptor expression in adolescent rats.

Authors:  Rosemarie M Booze; David R Wallace; Janelle M Silvers; Barbara J Strupp; Diane M Snow; Charles F Mactutus
Journal:  BMC Neurosci       Date:  2006-04-18       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.